Introduction

The healthcare ecosystem in New Zealand is embracing advanced medical technologies, with infusion pumps playing a vital role in modern patient care. These devices ensure precise and controlled delivery of medications, fluids, and nutrients, making them essential in hospitals, clinics, and home healthcare environments.

With the rise of connected healthcare systems, infusion pumps are increasingly integrated with hospital networks, cloud platforms, and remote monitoring applications. While this connectivity enhances efficiency and treatment accuracy, it also introduces cybersecurity risks such as unauthorized access, data breaches, and device manipulation.

To enter global markets and meet regulatory expectations, infusion pump manufacturers must comply with stringent frameworks such as the EU MDR and the FDA 510(k). These regulations require robust cybersecurity validation as part of device safety and performance.

Cyberintelsys supports manufacturers in New Zealand by delivering specialized security testing services aligned with these regulatory requirements, ensuring secure, compliant, and market-ready infusion pump devices.

Regulatory Alignment for Infusion Pump Security

Infusion pumps are classified as critical medical devices due to their direct impact on patient treatment. Regulatory bodies mandate strict cybersecurity controls to ensure safety, reliability, and resilience.

EU MDR Cybersecurity Requirements

Aligned with EU MDR, manufacturers must:

• Incorporate cybersecurity into product design and development

• Conduct risk management aligned with ISO 14971

• Protect devices against unauthorized access and tampering

• Ensure a secure software development lifecycle (SDLC)

• Implement post-market monitoring and vulnerability management

Cybersecurity is a core safety requirement under EU MDR, especially for connected and software-driven infusion pumps.

FDA 510(k) Cybersecurity Requirements

Based on FDA cybersecurity guidance, manufacturers are expected to:

• Perform detailed cybersecurity risk assessments

• Provide a Software Bill of Materials (SBOM)

• Demonstrate secure system architecture

• Conduct penetration testing and vulnerability validation

• Ensure secure patching and update mechanisms

The FDA emphasizes continuous risk management and proactive security measures throughout the device lifecycle.

Importance of Security Assessment for Infusion Pumps

Infusion pumps directly influence patient outcomes, making cybersecurity assessments critical to ensuring safe and reliable operation.

Key Benefits of Security Testing

• Patient Safety Protection
  Prevents unauthorized changes to dosage delivery and device functionality

• Regulatory Compliance
  Ensures adherence to EU MDR and FDA 510(k) requirements

• Data Protection
  Secures sensitive patient and clinical data from breaches

• Cyberattack Prevention
  Mitigates risks such as ransomware, unauthorized access, and device hijacking

• Global Market Access
  Enables successful entry into regulated international markets

A proactive approach to cybersecurity strengthens both device integrity and stakeholder trust.

Our Methodology – Infusion Pump Security Testing

Cyberintelsys follows a structured Infusion Pump Security Testing Methodology aligned with global regulatory expectations and industry best practices.

1. Device Architecture Review

• Analysis of hardware, firmware, and software components

• Identification of communication interfaces and entry points

• Mapping of system architecture and trust boundaries

2. Threat Modeling & Risk Analysis

• Identification of threat actors and attack vectors

• Risk assessment aligned with ISO 14971 and FDA guidance

• Prioritization based on patient safety impact

3. Vulnerability Assessment

• Automated and manual scanning of device components

• Identification of known vulnerabilities and misconfigurations

• Evaluation of exposed services and insecure configurations

4. Penetration Testing

• Simulation of real-world cyberattacks

• Testing authentication, authorization, and encryption controls

• Exploitation attempts to validate risk severity

5. Firmware & Embedded Security Testing

• Reverse engineering and firmware analysis

• Detection of hardcoded credentials and insecure logic

• Validation of secure boot and firmware update mechanisms

6. Network & Communication Security Testing

• Analysis of data transmission protocols

• Detection of encryption weaknesses

• Man-in-the-middle (MITM) attack simulations

7. Compliance Mapping & Reporting

• Mapping findings to EU MDR and FDA 510(k) requirements

• Detailed reporting with remediation recommendations

• Documentation support for regulatory submissions

Cyberintelsys Services for Infusion Pump Security

Cyberintelsys delivers comprehensive cybersecurity services tailored for infusion pump manufacturers aiming for global compliance.

Core Security Services

• Vulnerability Assessment (VA)
  Identification of security weaknesses across device components, applications, and infrastructure using advanced tools and expert analysis.

• Penetration Testing (PT)
  Real-world attack simulations to evaluate device resilience and identify exploitable vulnerabilities.

• Firmware Security Testing
  Detailed analysis of embedded systems to uncover hidden vulnerabilities and insecure coding practices.

• Network Security Testing
  Evaluation of communication protocols, APIs, and backend integrations to ensure secure data exchange.

• Web & Cloud Security Testing
  Security assessment of associated platforms such as dashboards, mobile applications, and cloud-based systems.

• SBOM Analysis & Component Risk Management
  Identification and evaluation of third-party components and associated vulnerabilities.

• Secure Code Review
  Manual and automated code analysis to detect and remediate security flaws early in development.

• Regulatory Compliance Support
  Assistance with documentation, reporting, and submission requirements for EU MDR and FDA 510(k).

Why Choose Cyberintelsys

Selecting the right cybersecurity partner is essential for achieving compliance and ensuring patient safety.

• Strong Regulatory Expertise
  In-depth knowledge of EU MDR and FDA cybersecurity requirements

• Medical Device Security Focus
  Specialized experience in connected healthcare technologies

• End-to-End Testing Coverage
  From embedded systems to cloud ecosystems

• Risk-Based Approach
  Focus on vulnerabilities impacting patient safety and device functionality

• Clear & Actionable Reporting
  Practical remediation guidance with structured documentation

• Global Delivery Capability
  Supporting manufacturers in New Zealand and international markets

Cyberintelsys is a CREST-accredited cybersecurity company for Vulnerability Assessment (VA) and Penetration Testing (PT), delivering industry-recognized security testing services for organizations across multiple sectors.

Contact Cyberintelsys

As New Zealand continues to adopt connected healthcare technologies, ensuring the cybersecurity of infusion pumps is critical for both compliance and patient safety.

Cyberintelsys supports medical device manufacturers with end-to-end security testing services aligned with EU MDR and FDA 510(k), helping ensure secure product deployment and successful regulatory approvals.

Whether preparing for international market entry or strengthening existing device security, the right cybersecurity approach is essential.

Contact Cyberintelsys today to secure your infusion pump devices and confidently meet global regulatory requirements.